Patients with hypertension (HTN) are often asymptomatic, but the consequences, if left untreated, may be devastating. The Kidney Disease: Improving Global Outcomes provides national guidelines in clinical practice for blood pressure control in the non-dialysis-dependent chronic kidney disease population. However, clearly defined guidelines are not available for hypertensive patients in the hemodialysis (HD) population. For practicing physicians, the absence of a specific protocol may present challenges in managing such patients admitted to the hospital for hypertensive urgency. Thus, the goal of this paper was to conduct a literature search and identify specific interventions for this patient population. Although additional studies are needed to adequately draw therapeutic conclusions, the proposed algorithm serves as a summary of the recommendations presented in current literature.

Whether a patient is in an early stage of kidney disease or has progressed to end-stage renal disease (ESRD) and is dependent on dialysis, maintaining blood pressure continues to play a critical role. A systematic review and meta-analysis of randomized controlled trials published in 2009 reported that blood pressure--lowering treatment was associated with a reduced risk of cardiovascular events, all-cause mortality, and cardiovascular mortality in dialysis patients ([@CIT0001]).

HD provides better volume control in ESRD patients by achieving a patient\'s dry weight, defined as the postdialysis body mass at which the patient neither retains excess fluid nor experiences symptoms of hypotension. Even with HD, however, nearly 50--60% of patients continue to suffer from HTN ([@CIT0002]). As such, additional strategies to reduce blood pressure should be implemented alongside the dialysis plan. The HTN management options to achieve volume control that were investigated in this article include:Prolonged or increased frequency of HDSodium control (dietary and dialysate sodium prescriptions)Antihypertensive agentsSympathetic denervationBilateral nephrectomyBioimpedance spectroscopy

Methods {#S0002}
=======

The search for HTN management options in the HD population was conducted using PubMed (Medline). We identified relevant literature, particularly those using the systematic review and meta-analysis methodologies. Articles included were limited to humans and the English language. The search keywords applied are shown in [Table 1](#T0001){ref-type="table"}. If relevant systematic reviews or meta-analysis were not found, the search criteria were broadened to include all other forms of literature by removing the systematic review and meta-analysis filter.

###### 

Search keywords for advanced PubMed search with systematic review, meta-analysis, or no filter specified

  -----------------------------------------------
  **Medical subject headings (MeSH) keywords:**
  Dialysis solution+hypertension
  Hypertension+hemodialysis
  Kidney failure, chronic+hypertension
  Anti-HTN medication+hemodialysis
  -----------------------------------------------

Results {#S0003}
=======

The literature selected for this project is summarized in [Table 2](#T0002){ref-type="table"}.

###### 

Summary of literature findings

  ------------------------------------------------------------------------------------------------------------------
  Intervention                Type of literature                               Special notes
  --------------------------- ------------------------------------------------ -------------------------------------
  Short-daily HD              1 systematic review\                             
                              1 meta-analysis                                  

  Nocturnal HD                1 systematic review                              

  Sodium restriction          1 combined systematic review and meta-analysis   Article not specific to HD patients

  Sodium dialysate solution   1 in-depth review\                               
                              1 clinical trial                                 

  Anti-HTN medication         1 combined systematic review and meta-analysis   

  Sympathetic denervation     1 systematic review\                             SR not specific to HD patients
                              1 case report (HD +HTN patient)                  

  Bilateral nephrectomy       1 clinical trial                                 

  Bioimpedance spectroscopy   1 clinical trial                                 
  ------------------------------------------------------------------------------------------------------------------

Eight interventions were investigated for managing HTN in the HD population; seven showed benefits in patient care as measured by improvements in blood pressure control, decrease in prescribed antihypertensive medications, or less interdialytic weight gain. The description and findings from each intervention are summarized in [Table 3](#T0003){ref-type="table"}.

###### 

Summary of literature search results for the management of hypertension in hemodialysis patients in intervention groups

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Intervention                                Description of technique                                                                                                                             Findings
  ------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Short-daily HD ([@CIT0003], [@CIT0004])     • Performed approximately 5--7 times per week for 1.5--3 hour duration                                                                               • Improvements in blood pressure control • Discontinuation or reduction in mean number of

  Nocturnal HD ([@CIT0005])                   • Performed approximately 6 nights a week                                                                                                            anti-HTN drugs

  Sodium restriction ([@CIT0006])             • Restricting dietary sodium leads to less water retention and interdialytic weight gains                                                            • Greater blood pressure drop in hypertensive patients than general population\
                                                                                                                                                                                                   • Daily sodium intake ≤2 grams recommended

  Sodium profiling ([@CIT0007], [@CIT0008])   • Gradual reduction of sodium dialysate concentration to match patient\'s individualized plasma sodium level (normal range between 135--145 mEq/L)   • Pre-HD sodium concentration is a safe and effective means to manage HTN in HD patients • Modest reductions decrease blood pressure and are well-tolerated in non-hypotensive prone patients\
                                                                                                                                                                                                   • Decrease in interdialytic weight gain

  Anti-HTN agents ([@CIT0001])                • Many classes with different targets\                                                                                                               • In general, reduced cardiovascular morbidity and mortality\
                                              ○ Adrenergic receptor antagonists (α-blockers, β-blockers)\                                                                                          • β-Blockers, CCBs, ACE inhibitors, and ARBs are appropriate primary choices for HD patients\
                                              ○ Calcium channel blockers (CCB)\                                                                                                                    • α-Blockers and central acting agents recommended as secondary choices\
                                              ○ ACE inhibitors and ARBs\                                                                                                                           • Assign medication according to patient comorbidities
                                              ○ Centrally acting agents                                                                                                                            

  Sympathetic denervation ([@CIT0009])        • Catheter-based radiofrequency energy interrupts sympathetic nervous system in renal arteries                                                       • Patients with resistant HTN showed significant reduction in systolic and diastolic pressures with no reported worsening of kidney function postdenervation

  Bilateral nephrectomy ([@CIT0010])          • Removing kidneys reduces circulating levels of renin, angiotensin I and angiotensin II                                                             • Largely abandoned with introduction of anti-HTN medication\
                                                                                                                                                                                                   • Rarely practiced due to negative outcomes

  Bioimpedance spectroscopy ([@CIT0011])      • Recently proposed technique using fluid model to determine fluid overload                                                                          • Decrease in postdialysis body weight, better blood pressure levels and decreased use of anti-HTN medication
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Algorithm {#S0004}
=========

An algorithm summarizing the findings from the literature review was proposed to serve as an initial guide to managing HD patients admitted for hypertensive urgency because specific guidelines are not currently available. Until further investigation and recommendations can be made, this algorithm provides a stepwise approach that may assist physicians in optimizing care from acute presentation to long-term management.

In the acute setting, a HD patient with fluid overload should be given pharmacologic intervention as they are prepared for emergency dialysis. Common intravenous medications administered include labetalol and nicardipine. Once stabilized, long-term management strategies should be implemented. Common home medication regimens include β-blockers, calcium channel blockers, Angiotensin converting enzyme inhibitors (ACE inhibitors), and Angiotensin receptor blockers (ARBs). Because some parameters may present ambiguity, [Table 4](#T0004){ref-type="table"} clarifies factors presented in the algorithm that may be difficult to define in clinical practice [Fig. 1](#F0001){ref-type="fig"}.

![Proposed algorithm for the management of hypertension in a hemodialysis patient admitted to the hospital for hypertensive urgency.](JCHIMP-4-24055-g001){#F0001}

###### 

Clarification of parameters presented in algorithm that may be difficult to assess

  --------------------------------- -------------------------------------------------------------------------------------
  Life style modification           • Salt restriction and healthy diet\
                                    • Weight control (interdialytic weight gain)\
                                    • Exercise\
                                    • Monitor daily blood pressure

  Response to anti-HTN medication   • Ensure patient receiving optimal and/or maximum recommended dose\
                                    • Consider changing or adding anti-HTN meds to treatment regimen\
                                    • Take individual patient characteristics (e.g., race, comorbidities)  into account

  Compliance with medication        • Cost of medication\
                                    • Mental status\
                                    • Education\
                                    • Gross negligence

  Secondary HTN                     • Examples include: renovascular disease and hyperaldosteronism
  --------------------------------- -------------------------------------------------------------------------------------

Conclusion {#S0005}
==========

The goal of this article was to search the PubMed database and broadly address the clinical question of how to manage HTN in HD patients, a population for whom specific guidelines are not currently available. Because the underlying mechanism and pathophysiology of acute and chronic HTN are similar, the literature findings were applied to both immediate and long-term patient care. Although additional research and investigation are required to optimize care, the proposed algorithm provides a stepping stone for practicing physicians faced with the clinical scenario described.

Although the algorithm presented suggests a linear approach, it is important to note that multiple management modalities may benefit a single patient and treatment options are not mutually exclusive. Additionally, it is imperative to take a patient\'s individual health status, comorbidities, and personal preferences into account when providing care. Perhaps the most important factor to consider after stabilizing a HD patient admitted for hypertensive urgency is adherence to the assigned treatment regimen. Explaining the significance of patient cooperation may present the most efficient and proactive method of treatment. Once established, the additional management methodologies presented in this article are beneficial in optimizing a patient\'s quality of life.
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